文献速递泌尿生殖MRUS

联合US/mp-MRI融合引导靶向穿刺与系统性US穿刺的组织学结果分析:mp-MRI在前列腺癌检出与假阴性中的作用

Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
PubMed 文献 · Radiol Med · 2017-10-10

研究纳入96例患者共137个mp-MRI可疑前列腺病灶,按PI-RADS v2评分后行US/mp-MRI融合靶向穿刺并以US引导12针系统随机穿刺补全采样。癌、不典型增生与良性组PI-RADS评分分别为4.41、3.61、3.24,差异有统计学意义;系统采样中检出130个(11.25%)mp-MRI假阴性,联合采样假阴性率为3.49%。

要点

  • 癌组PI-RADS评分4.41高于不典型增生组3.61和良性组3.24,差异有统计学意义。
  • mp-MRI对直径>15 mm病灶及PSA>6 ng/ml患者诊断更准确。
  • 系统穿刺检出mp-MRI假阴性130个(11.25%),联合采样假阴性率降至3.49%。

核心结论

  • mp-MRI仍是识别前列腺癌病灶的首选影像方法;将US引导随机采样与US/mp-MRI融合靶向病灶采样结合,可检出3.49%的假阴性。

研究设计与样本

  • 96例患者共137个mp-MRI(1.5T)可疑前列腺病灶,按PI-RADS v2评分,全部靶病灶行US/mp-MRI融合穿刺并以US引导系统随机12针穿刺补全;对所有样本行组织学分析与Gleason评分,以组织学结果为参考。

诊断标准与关键数值

  • 癌组PI-RADS评分4.41 vs 不典型增生组3.61 vs 良性组3.24,差异有统计学意义;Gleason>7组PI-RADS评分4.79 vs Gleason<7组4.14,差异有统计学意义;系统采样中mp-MRI假阴性130个(11.25%),联合采样假阴性率3.49%。

临床应用与阅片要点

  • mp-MRI对直径>15 mm病灶及PSA>6 ng/ml患者诊断更准确;系统随机穿刺可补检mp-MRI假阴性病灶,联合采样假阴性率为3.49%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS AND OBJECTIVES: To evaluate the diagnostic accuracy of mp-MRI correlating US/mp-MRI fusion-guided biopsy with systematic random US-guided biopsy in prostate cancer diagnosis.

MATERIALS AND METHODS: 137 suspected prostatic abnormalities were identified on mp-MRI (1.5T) in 96 patients and classified according to PI-RADS score v2. All target lesions underwent US/mp-MRI fusion biopsy and prostatic sampling was completed by US-guided systematic random 12-core biopsies. Histological analysis and Gleason score were established for all the samples, both target lesions defined by mp-MRI, and random biopsies. PI-RADS score was correlated with the histological results, divided in three groups (benign tissue, atypia and carcinoma) and with Gleason groups, divided in four categories considering the new Grading system of the ISUP 2014, using t test. Multivariate analysis was used to correlate PI-RADS and Gleason categories to PSA level and abnormalities axial diameter. When the random core biopsies showed carcinoma (mp-MRI false-negatives), PSA value and lesions Gleason median value were compared with those of carcinomas identified by mp-MRI (true-positives), using t test.

RESULTS: There was statistically significant difference between PI-RADS score in carcinoma, atypia and benign lesions groups (4.41, 3.61 and 3.24, respectively) and between PI-RADS score in Gleason < 7 group and Gleason > 7 group (4.14 and 4.79, respectively). mp-MRI performance was more accurate for lesions > 15 mm and in patients with PSA > 6 ng/ml. In systematic sampling, 130 (11.25%) mp-MRI false-negative were identified. There was no statistic difference in Gleason median value (7.0 vs 7.06) between this group and the mp-MRI true-positives, but a significant lower PSA median value was demonstrated (7.08 vs 7.53 ng/ml).

CONCLUSION: mp-MRI remains the imaging modality of choice to identify PCa lesions. Integrating US-guided random sampling with US/mp-MRI fusion target lesions sampling, 3.49% of false-negative were identified.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Faiella E, Santucci D, Greco F, et al. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative. Radiol Med. 2017. PMID: 29019021. doi:10.1007/s11547-017-0814-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。